|
Market Closed -
NYSE
06:01:40 17/06/26 am AEST
|
5-day change
|
1st Jan Change
|
|
115.17 USD
|
+0.23%
|
|
-3.70%
|
+9.41%
|
|
23/02 |
Merck & Co., Inc. Announces Executive Appointments and Organizational Changes in Human Health Business
|
CI
| |
13/02 |
Merck & Co. Insider Sold Shares Worth $1,214,562, According to a Recent SEC Filing
|
MT
| |
11/02 |
Merck & Co. Insider Sold Shares Worth $1,202,844, According to a Recent SEC Filing
|
MT
| |
10/02 |
Merck & Co. Insider Sold Shares Worth $14,485,690, According to a Recent SEC Filing
|
MT
| |
07/02 |
Merck & Co. Insider Sold Shares Worth $1,827,992, According to a Recent SEC Filing
|
MT
| |
07/02 |
Merck & Co. Insider Sold Shares Worth $765,920, According to a Recent SEC Filing
|
MT
| |
07/02 |
Merck & Co. Insider Sold Shares Worth $4,557,025, According to a Recent SEC Filing
|
MT
| |
08/01 |
Vaxxas appoints former Merck global vaccines president David Peacock as CEO
|
RE
| |
13/11 |
Merck & Co. Insider Sold Shares Worth $616,395, According to a Recent SEC Filing
|
MT
| |
05/11 |
Merck & Co. Insider Sold Shares Worth $720,040, According to a Recent SEC Filing
|
MT
| |
10/07/25 |
Merck to Buy Verona Pharma for About $10B
|
MT
| |
25/06/25 |
US CDC's report shows no evidence linking thimerosal-containing vaccines and autism
|
RE
| |
21/02/25 |
Merck & Co. Insider Sold Shares Worth $714,745, According to a Recent SEC Filing
|
MT
| |
14/02/25 |
Merck & Co. Insider Sold Shares Worth $512,057, According to a Recent SEC Filing
|
MT
| |
23/11/24 |
Merck: Emerson Electric CEO to join board
|  | |
22/11/24 |
Merck & Co., Inc. Appoints Surendralal L. Karsanbha to its Board of Directors, Effective January 1, 2025
|
CI
| |
16/02/24 |
Merck & Co. Insider Sold Shares Worth $29,538,998, According to a Recent SEC Filing
|
MT
| |
16/02/24 |
Merck & Co. Insider Sold Shares Worth $4,805,521, According to a Recent SEC Filing
|
MT
| |
13/02/24 |
Merck & Co. Insider Sold Shares Worth $1,845,083, According to a Recent SEC Filing
|
MT
| |
06/02/24 |
Merck & Co. Insider Sold Shares Worth $2,411,111, According to a Recent SEC Filing
|
MT
| |
03/02/24 |
Merck & Co. Insider Sold Shares Worth $6,420,349, According to a Recent SEC Filing
|
MT
| |
29/11/23 |
Merck & Co., Inc. Announces Management Changes, Effective on December 4, 2023
|
CI
| |
14/11/23 |
Merck & Co. Insider Sold Shares Worth $213,061, According to a Recent SEC Filing
|
MT
| |
10/11/23 |
Merck & Co. Insider Sold Shares Worth $4,602,668, According to a Recent SEC Filing
|
MT
| |
16/08/23 |
Insider Sell: Merck & Co.
|
MT
|
No results match your criteria
Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
|